Pathologic response and survival after cisplatin, pemetrexed, and bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer

被引：0
|
作者：
Tsutani, Y. [1 ]
Miyata, Y. [1 ]
Suzuki, K. [2 ]
Takamochi, K. [2 ]
Tanaka, F. [3 ]
Nakayama, H. [4 ]
Yamashita, Y. [5 ]
Oda, M. [6 ]
Tsuboi, M. [7 ]
Okada, M. [1 ]
机构：
[1] Hiroshima Univ, Surg Oncol, Hiroshima, Japan
[2] Juntendo Univ, Gen Thorac Surg, Sch Med, Tokyo, Japan
[3] Univ Occupat & Environm Hlth, Thorac Surg, Kitakyushu, Fukuoka, Japan
[4] Kanagawa Canc Ctr, Thorac Surg, Yokohama, Kanagawa, Japan
[5] Chugoku Canc Ctr, Kure Med Ctr, Thorac Surg, Kure, Japan
[6] Kanazawa Univ, Thorac Surg, Kanazawa, Ishikawa, Japan
[7] Natl Canc Ctr Hosp East, Thorac Surg & Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw382.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1197P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer
    Tomoshi Tsuchiya
    Keitaro Matsumoto
    Takuro Miyazaki
    Hiroyuki Yamaguchi
    Takuya Yamazaki
    Isao Sano
    Junya Fukuoka
    Yoichi Nakamura
    Naoya Yamasaki
    Takeshi Nagayasu
    General Thoracic and Cardiovascular Surgery, 2019, 67 : 537 - 543
  • [32] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice
    Zugazagoitia, J.
    Puente, J.
    Gonzalez-Larriba, J. L.
    Manzano, A.
    Sotelo, M.
    Hernandez, S.
    Sanz, J.
    Perez, P.
    Diaz-Rubio, E.
    ONCOLOGY, 2013, 84 (05) : 255 - 264
  • [34] RESPONSE RATES TO CARBOPLATIN AND PEMETREXED IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - A SINGLE CENTRE AUDIT
    Talbot, Toby L. J.
    Collinson, Matthew P.
    Buscombe, Charlotte
    Pascoe, Susan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1210 - S1210
  • [35] A retrospective study of maintenance pemetrexed in advanced non-squamous non-small cell lung cancer
    Oguh, L.
    Ranatunge, D.
    Lind, M.
    Ukadhyay, S.
    El-Mahdawi, N.
    LUNG CANCER, 2018, 115 : S30 - S30
  • [36] Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for previously untreated advanced non-squamous non-small cell lung cancer
    Uenami, T.
    Koba, T.
    Minami, S.
    Futami, Y.
    Masuhiro, K.
    Kimura, H.
    Futami, S.
    Yaga, M.
    Mori, M.
    Kagawa, H.
    Komo, S.
    Otsuka, T.
    Yamamoto, S.
    Komuta, K.
    Kijima, T.
    ANNALS OF ONCOLOGY, 2017, 28 : 141 - 141
  • [37] A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)
    Taichi Takashina
    Hajime Asahina
    Satoshi Oizumi
    Noriyuki Yamada
    Masao Harada
    Kei Takamura
    Hiroshi Yokouchi
    Toshiyuki Harada
    Osamu Honjo
    Takahiro Ogi
    Naoto Morikawa
    Ichiro Kinoshita
    Ryoichi Honda
    Kosuke Nakano
    Kenya Kanazawa
    Toraji Amano
    Hirotoshi Dosaka-Akita
    Hiroshi Isobe
    Masaharu Nishimura
    International Journal of Clinical Oncology, 2018, 23 : 1060 - 1069
  • [38] A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)
    Takashina, Taichi
    Asahina, Hajime
    Oizumi, Satoshi
    Yamada, Noriyuki
    Harada, Masao
    Takamura, Kei
    Yokouchi, Hiroshi
    Harada, Toshiyuki
    Honjo, Osamu
    Ogi, Takahiro
    Morikawa, Naoto
    Kinoshita, Ichiro
    Honda, Ryoichi
    Nakano, Kosuke
    Kanazawa, Kenya
    Amano, Toraji
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (06) : 1060 - 1069
  • [39] TOLERANCE AND EFFICACY OF PEMETREXED-CISPLATIN FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER A GALICIAN LUNG CANCER GROUP STUDY
    Senin, Clara
    Campos, Begona
    Jose Villanueva, Maria
    Firvida, J. L.
    Baron, Francisco
    Amenedo, Margarita
    Afonso, Javier
    Lazaro, Martin
    Varela, S.
    Grande, C.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1277 - S1277
  • [40] Efficacy and Safety of Pemetrexed-Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer - a Galician Lung Cancer Group Study
    Senin, C.
    Varela, S.
    Huidobro, G.
    Firvida, J. L.
    Baron, F.
    Amenedo, M.
    Afonso, F. J.
    Lazaro, M.
    Campos, B.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S624 - S624
12345